Semax + Selank

Commercial or common name

Semax + Selank. This name is not standardized.

Reported formulation variants

• Separate or combined intranasal products

What the combination shows

No adequate human combination evidence was identified in the static MVP review. Component-level findings do not transfer to the combination.

Status

Unapproved / RUO. No approval is implied by use of a commercial or community name.

Combination trial status

No validated human combination trial identified

Stability and compatibility

Compatibility, sterility and stability are not established across marketed variants

Common marketing claims

• Focus
• Anxiety
• Cognition